Our top pick for
Building a portfolio

Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.
iHuman Inc is an education & training services business based in the US. iHuman shares (IH) are listed on the NYSE and all prices are listed in US Dollars. iHuman employs 437 staff and has a market cap (total outstanding shares value) of USD0.00.
Our top pick for
Building a portfolio
Our top pick for
Beginners
Our top pick for
Active traders
52-week range | USD$12.12 - USD$30 |
---|---|
50-day moving average | USD$19.0279 |
200-day moving average | USD$20.8745 |
Wall St. target price | USD$16.05 |
PE ratio | 24160.2 |
Dividend yield | N/A (0%) |
Earnings per share (TTM) | USD$0.0008 |
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Valuing iHuman stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of iHuman's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
iHuman's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 24160x. In other words, iHuman shares trade at around 24160x recent earnings.
That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.
However, iHuman's P/E ratio is best considered in relation to those of others within the education & training services industry or those of similar companies.
Gross profit TTM | USD$134.5 million |
---|---|
Return on assets TTM | 0% |
Return on equity TTM | -9999999% |
Profit margin | 2.44% |
Book value | N/A |
Market capitalisation | USD$771 million |
TTM: trailing 12 months
There are currently 56,942 iHuman shares held short by investors – that's known as iHuman's "short interest". This figure is 68.7% up from 33,762 last month.
There are a few different ways that this level of interest in shorting iHuman shares can be evaluated.
iHuman's "short interest ratio" (SIR) is the quantity of iHuman shares currently shorted divided by the average quantity of iHuman shares traded daily (recently around 116208.16326531). iHuman's SIR currently stands at 0.49. In other words for every 100,000 iHuman shares traded daily on the market, roughly 490 shares are currently held short.
To gain some more context, you can compare iHuman's short interest ratio against those of similar companies.
However iHuman's short interest can also be evaluated against the total number of iHuman shares, or, against the total number of tradable iHuman shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case iHuman's short interest could be expressed as 0% of the outstanding shares (for every 100,000 iHuman shares in existence, roughly 0 shares are currently held short) or 0% of the tradable shares (for every 100,000 tradable iHuman shares, roughly 0 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against iHuman.
Find out more about how you can short iHuman stock.
We're not expecting iHuman to pay a dividend over the next 12 months.
You may also wish to consider:
iHuman Inc. provides childhood edutainment products and services to individual users, education organizations, and distributors in the People's Republic of China. The company offers interactive and self-directed learning apps, including iHuman Chinese, iHuman English World, iHuman Pinyin, iHuman Magic Math, iHuman Books, and iHuman Stories. It also provides learning materials in physical and digital formats; and smart learning devices. The company was founded in 1996 and is based in Beijing, the People's Republic of China. .
Features, fees and complaints to consider before you apply for a T. Rowe Price account.
Steps to owning and managing ZTO, with 24-hour and historical pricing before you buy.
Steps to owning and managing ZOM, with 24-hour and historical pricing before you buy.
Steps to owning and managing ZI, with 24-hour and historical pricing before you buy.
Steps to owning and managing ZKIN, with 24-hour and historical pricing before you buy.
Steps to owning and managing ZION, with 24-hour and historical pricing before you buy.
Steps to owning and managing ZNTL, with 24-hour and historical pricing before you buy.
Steps to owning and managing ZGYH, with 24-hour and historical pricing before you buy.
Steps to owning and managing ZEAL, with 24-hour and historical pricing before you buy.
Steps to owning and managing CTIB, with 24-hour and historical pricing before you buy.